Sign in

Research summary ·

Comparative Effectiveness of Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors, and Anticonvulsants for Diabetic Painful Neuropathy: A Systematic Review and Meta-Analysis.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study pooled results from earlier drug trials. It looked at pain from nerve damage caused by diabetes. It set these drugs side by side: amitriptyline, duloxetine, gabapentin and pregabalin. In each trial, the drug was given alone. The team looked for trials from 2010 to 2025. They found 11 trials with 1397 people in all. They put the pain scores from each trial on one shared scale.

What they found

Duloxetine, gabapentin and pregabalin each cut pain by a clear amount. Each amitriptyline trial showed some gain on its own. But when these trials were pooled, the result was not clear enough. A second method set the drugs against each other. Gabapentin, duloxetine and amitriptyline seemed to ease pain more than pregabalin. The gaps between those drugs were modest and not clear. Extra checks gave the same picture.

What it means for patients

The authors say these drugs give much the same pain relief. In their analysis, gabapentin came out ahead. Still, the gaps between the drugs were modest. People also react to these drugs in very different ways. So the authors say the choice of drug should fit each person. They point to other health problems a person has. They also point to how well the drug is put up with. Treatment goals matter too.

Why it is not certain yet

Only 11 trials were part of this review. Some drug pairs were judged from indirect links between trials. The authors say larger trials are needed. They also want trials that all use the same methods. A review can only be as good as the studies in it.

Source

Comparative Effectiveness of Tricyclic Antidepressants, Serotonin-Norepinephrine Reuptake Inhibitors, and Anticonvulsants for Diabetic Painful Neuropathy: A Systematic Review and Meta-Analysis.

PubMed · PMID 42930568

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Diabetic neuropathy publications